See more : SK oceanplant Co.,Ltd (100090.KS) Income Statement Analysis – Financial Results
Complete financial analysis of Nano-X Imaging Ltd. (NNOX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nano-X Imaging Ltd., a leading company in the Medical – Devices industry within the Healthcare sector.
- Sezzle Inc. (SEZNL) Income Statement Analysis – Financial Results
- Southern Copper Corporation (SCCO) Income Statement Analysis – Financial Results
- Octava Minerals Limited (OCT.AX) Income Statement Analysis – Financial Results
- Central China Securities Co., Ltd. (601375.SS) Income Statement Analysis – Financial Results
- Tai Ping Carpets International Limited (TAPCF) Income Statement Analysis – Financial Results
Nano-X Imaging Ltd. (NNOX)
About Nano-X Imaging Ltd.
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company develops a prototype of the Nanox.ARC, a medical imaging system incorporating its digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that would allow for the delivery of medical screening as a service. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company was founded in 2011 and is headquartered in Neve Ilan, Israel.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 9.91M | 8.58M | 1.30M | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 16.50M | 15.46M | 2.82M | 208.00K | 53.00K | 35.00K |
| Gross Profit | -6.59M | -6.88M | -1.51M | -208.00K | -53.00K | -35.00K |
| Gross Profit Ratio | -66.55% | -80.21% | -115.95% | 0.00% | 0.00% | 0.00% |
| Research & Development | 26.05M | 26.51M | 17.12M | 9.21M | 2.72M | 672.00K |
| General & Administrative | 26.01M | 41.25M | 34.71M | 22.27M | 18.30M | 1.02M |
| Selling & Marketing | 2.38M | 4.38M | 7.03M | 12.45M | 1.56M | 209.00K |
| SG&A | 28.39M | 45.63M | 41.74M | 34.71M | 19.85M | 1.23M |
| Other Expenses | 1.55M | 191.00K | 1.18M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 56.00M | 72.33M | 60.05M | 43.92M | 22.57M | 1.90M |
| Cost & Expenses | 72.49M | 87.79M | 62.86M | 43.92M | 22.57M | 1.90M |
| Interest Income | 1.65M | 789.00K | 288.00K | 108.00K | 8.00K | 0.00 |
| Interest Expense | 0.00 | 60.22M | 288.00K | 0.00 | 0.00 | 5.00K |
| Depreciation & Amortization | 11.81M | 11.51M | 2.29M | 208.00K | 53.00K | 35.00K |
| EBITDA | -47.69M | -75.70M | -59.27M | -43.61M | -22.52M | -1.87M |
| EBITDA Ratio | -481.50% | -433.60% | -4,720.71% | 0.00% | 0.00% | 0.00% |
| Operating Income | -62.59M | -109.71M | -61.56M | -43.92M | -22.57M | -1.90M |
| Operating Income Ratio | -631.89% | -1,278.97% | -4,720.71% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 1.47M | -14.67M | -288.00K | 108.00K | 8.00K | -5.00K |
| Income Before Tax | -61.12M | -108.92M | -61.85M | -43.82M | -22.56M | -1.91M |
| Income Before Tax Ratio | -617.01% | -1,269.77% | -4,742.79% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -339.00K | -3.68M | -48.00K | -316.00K | -8.00K | 5.00K |
| Net Income | -60.78M | -105.24M | -61.80M | -43.50M | -22.56M | -1.91M |
| Net Income Ratio | -613.59% | -1,226.89% | -4,739.11% | 0.00% | 0.00% | 0.00% |
| EPS | -1.08 | -2.01 | -1.28 | -1.22 | -0.49 | -0.06 |
| EPS Diluted | -1.08 | -2.01 | -1.28 | -1.22 | -0.49 | -0.06 |
| Weighted Avg Shares Out | 56.37M | 52.24M | 48.22M | 35.65M | 45.72M | 34.17M |
| Weighted Avg Shares Out (Dil) | 56.37M | 52.24M | 48.22M | 35.65M | 45.72M | 34.17M |
Here's Why Nanox Stock Went Up Today
Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication
Nano-X Imaging Ltd. (NNOX) Q3 2024 Earnings Call Transcript
Nanox to Report Third Quarter and Financial Results on November 21, 2024
Nanox Highlighted on TIME's Best Inventions of 2024 List for its AI Solutions
Nanox to Participate in Upcoming Investor Conference in September 2024
Here's Why NanoX Imaging (NNOX) Could be Great Choice for a Bottom Fisher
Nanox Receives FDA Clearance for HealthCCSng V2.0, Upgraded Version of Advanced AI Cardiac Solution Empowering Physicians in Assessment of Coronary Artery Calcium
Nano-X Imaging Ltd. (NNOX) Q2 2024 Earnings Call Transcript
Nanox Announces Second Quarter of 2024 Financial Results and Provides Business Update
Source: https://incomestatements.info
Category: Stock Reports